CLINICAL NEWS
Results suggest that prophylactic
doses of LMWH should no
longer be routinely prescribed
for non-thrombophilic women
in this clinical setting.
“However, because a detrimental effect of aspirin could not be ruled
out and might explain the lack of efficacy of the combination with
LMWH, it was important to investigate the effect of LMWH alone – as
we did in our study,” she added. ●
References
• Pasquier E, de Saint Martin L, Bohec C, et al. Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter
randomized double-blind placebo-controlled trial. Blood. 2015 January 30. [Epub ahead of print]
• Clark P, Walker ID, et al. SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of lowmolecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. Blood. 201 X^H